Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Reciprocal control of G1-phase progression is required for Th-POK/Runx3-mediated CD4/8 thymocyte cell fate decision.

Sato T, Chiba T, Ohno S, Sato C, Sugoh T, Miyashita K, Akatsuka H, Hozumi K, Okada Y, Iida Y, Akatsuka A, Agata Y, Chiba M, Kohu K, Satake M, Tanabe H, Saya H, Habu S.

J Immunol. 2012 Nov 1;189(9):4426-36. doi: 10.4049/jimmunol.1102748. Epub 2012 Sep 26.

2.

Regulation of Th-POK and Runx3 in T cell development in human thymoma.

Tokunaga T, Hayashi A, Kadota Y, Shiono H, Inoue M, Sawabata N, Okumura M.

Autoimmunity. 2009;42(8):653-60. doi: 10.3109/08916930903120941.

PMID:
19886737
3.

Runx3 regulates integrin alpha E/CD103 and CD4 expression during development of CD4-/CD8+ T cells.

Grueter B, Petter M, Egawa T, Laule-Kilian K, Aldrian CJ, Wuerch A, Ludwig Y, Fukuyama H, Wardemann H, Waldschuetz R, Möröy T, Taniuchi I, Steimle V, Littman DR, Ehlers M.

J Immunol. 2005 Aug 1;175(3):1694-705. Erratum in: J Immunol. 2005 Nov 1;175(9):6238.

4.

Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development.

Setoguchi R, Tachibana M, Naoe Y, Muroi S, Akiyama K, Tezuka C, Okuda T, Taniuchi I.

Science. 2008 Feb 8;319(5864):822-5. doi: 10.1126/science.1151844.

5.

The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment.

He X, He X, Dave VP, Zhang Y, Hua X, Nicolas E, Xu W, Roe BA, Kappes DJ.

Nature. 2005 Feb 24;433(7028):826-33.

6.

p300-mediated acetylation stabilizes the Th-inducing POK factor.

Zhang M, Zhang J, Rui J, Liu X.

J Immunol. 2010 Oct 1;185(7):3960-9. doi: 10.4049/jimmunol.1001462. Epub 2010 Sep 1.

7.

Overexpression of the Runx3 transcription factor increases the proportion of mature thymocytes of the CD8 single-positive lineage.

Kohu K, Sato T, Ohno S, Hayashi K, Uchino R, Abe N, Nakazato M, Yoshida N, Kikuchi T, Iwakura Y, Inoue Y, Watanabe T, Habu S, Satake M.

J Immunol. 2005 Mar 1;174(5):2627-36.

9.

Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis.

Woolf E, Xiao C, Fainaru O, Lotem J, Rosen D, Negreanu V, Bernstein Y, Goldenberg D, Brenner O, Berke G, Levanon D, Groner Y.

Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7731-6. Epub 2003 Jun 9.

10.

Thpok-independent repression of Runx3 by Gata3 during CD4+ T-cell differentiation in the thymus.

Xiong Y, Castro E, Yagi R, Zhu J, Lesourne R, Love PE, Feigenbaum L, Bosselut R.

Eur J Immunol. 2013 Apr;43(4):918-28. doi: 10.1002/eji.201242944. Epub 2013 Feb 12.

11.

TCF-1 and LEF-1 act upstream of Th-POK to promote the CD4(+) T cell fate and interact with Runx3 to silence Cd4 in CD8(+) T cells.

Steinke FC, Yu S, Zhou X, He B, Yang W, Zhou B, Kawamoto H, Zhu J, Tan K, Xue HH.

Nat Immunol. 2014 Jul;15(7):646-656. doi: 10.1038/ni.2897. Epub 2014 May 18.

12.

MAZR and Runx Factors Synergistically Repress ThPOK during CD8+ T Cell Lineage Development.

Sakaguchi S, Hainberger D, Tizian C, Tanaka H, Okuda T, Taniuchi I, Ellmeier W.

J Immunol. 2015 Sep 15;195(6):2879-87. doi: 10.4049/jimmunol.1500387. Epub 2015 Aug 7.

13.

Regulation of thymocyte lineage commitment by the level of classical protein kinase C activity.

Ohoka Y, Kuwata T, Asada A, Zhao Y, Mukai M, Iwata M.

J Immunol. 1997 Jun 15;158(12):5707-16.

PMID:
9190920
14.

The zinc-finger protein MAZR is part of the transcription factor network that controls the CD4 versus CD8 lineage fate of double-positive thymocytes.

Sakaguchi S, Hombauer M, Bilic I, Naoe Y, Schebesta A, Taniuchi I, Ellmeier W.

Nat Immunol. 2010 May;11(5):442-8. doi: 10.1038/ni.1860. Epub 2010 Apr 11.

15.

CCR7 expression in developing thymocytes is linked to the CD4 versus CD8 lineage decision.

Yin X, Ladi E, Chan SW, Li O, Killeen N, Kappes DJ, Robey EA.

J Immunol. 2007 Dec 1;179(11):7358-64.

16.

Signals through CD8 or CD4 can induce commitment to the CD4 lineage in the thymus.

Bommhardt U, Cole MS, Tso JY, Zamoyska R.

Eur J Immunol. 1997 May;27(5):1152-63.

PMID:
9174605
17.

The network of transcription factors that underlie the CD4 versus CD8 lineage decision.

Naito T, Taniuchi I.

Int Immunol. 2010 Oct;22(10):791-6. doi: 10.1093/intimm/dxq436. Epub 2010 Aug 22. Review.

PMID:
20732858
18.

Antagonistic interplay between ThPOK and Runx in lineage choice of thymocytes.

Egawa T, Taniuchi I.

Blood Cells Mol Dis. 2009 Jul-Aug;43(1):27-9. doi: 10.1016/j.bcmd.2009.03.004. Epub 2009 Apr 16.

PMID:
19375362
19.

The duration of antigen receptor signalling determines CD4+ versus CD8+ T-cell lineage fate.

Yasutomo K, Doyle C, Miele L, Fuchs C, Germain RN.

Nature. 2000 Mar 30;404(6777):506-10. Erratum in: Nature 2000 Sep 7;407(6800):110.

PMID:
10761920
20.

Role of the transcription factor Th-POK in CD4:CD8 lineage commitment.

Kappes DJ, He X, He X.

Immunol Rev. 2006 Feb;209:237-52. Review.

PMID:
16448546

Supplemental Content

Support Center